IL286624A - Anesthetic composition and method of anesthetizing the eye - Google Patents

Anesthetic composition and method of anesthetizing the eye

Info

Publication number
IL286624A
IL286624A IL286624A IL28662421A IL286624A IL 286624 A IL286624 A IL 286624A IL 286624 A IL286624 A IL 286624A IL 28662421 A IL28662421 A IL 28662421A IL 286624 A IL286624 A IL 286624A
Authority
IL
Israel
Prior art keywords
anesthetizing
eye
anesthetic composition
anesthetic
composition
Prior art date
Application number
IL286624A
Other languages
Hebrew (he)
Inventor
Martin Uram
Original Assignee
Martin Uram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/024239 external-priority patent/WO2019191200A1/en
Application filed by Martin Uram filed Critical Martin Uram
Publication of IL286624A publication Critical patent/IL286624A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL286624A 2019-03-26 2021-09-23 Anesthetic composition and method of anesthetizing the eye IL286624A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962824207P 2019-03-26 2019-03-26
PCT/US2019/024239 WO2019191200A1 (en) 2018-03-27 2019-03-27 Method and formulation for producing anesthesia of internal aspect of eye wall by topical application
US16/811,798 US11096922B2 (en) 2018-03-27 2020-03-06 Anesthetic composition and method of anesthetizing the eye
PCT/US2020/022915 WO2020197816A1 (en) 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye

Publications (1)

Publication Number Publication Date
IL286624A true IL286624A (en) 2021-10-31

Family

ID=72609654

Family Applications (1)

Application Number Title Priority Date Filing Date
IL286624A IL286624A (en) 2019-03-26 2021-09-23 Anesthetic composition and method of anesthetizing the eye

Country Status (11)

Country Link
EP (1) EP3946311A4 (en)
JP (1) JP2022527621A (en)
KR (1) KR20210143254A (en)
CN (1) CN114072139A (en)
AU (1) AU2020245203A1 (en)
BR (1) BR112021019039A2 (en)
CA (1) CA3134531A1 (en)
IL (1) IL286624A (en)
MX (1) MX2021011589A (en)
SG (1) SG11202110423UA (en)
WO (1) WO2020197816A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300936T1 (en) * 1992-05-06 2005-08-15 Alcon Lab Inc APPLICATION OF BORAL-POLYOL COMPLEXES FOR OPHTHALMIC MEDICINAL COMPOSITIONS
AU2002360939A1 (en) * 2001-11-21 2003-06-10 Novartis Ag Composition for stabilizing hyaluronic acid
CN101695488B (en) * 2009-11-05 2012-05-02 蚌埠丰原涂山制药有限公司 Compound articaine freeze-drying preparation for injection and preparation method thereof
CN101721407B (en) * 2009-11-23 2013-04-10 蚌埠丰原涂山制药有限公司 Compound articaine hydrochloride injection and preparation method thereof
FR2968996B1 (en) * 2010-12-17 2013-04-12 Anteis Sa AQUEOUS INJECTABLE STERILE FORMULATION USED IN OPHTHALMOLOGY
FR3036035B1 (en) * 2015-05-11 2018-10-05 Laboratoires Vivacy COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC
CA2998134A1 (en) * 2015-09-08 2017-03-16 Viewpoint Therapeutics, Inc. Compounds and formulations for treating ophthalmic diseases
WO2018220283A1 (en) * 2017-05-29 2018-12-06 Kh Medtech Sarl Sterile injectable composition containing cross-linked hyaluronic acid and articaine

Also Published As

Publication number Publication date
BR112021019039A2 (en) 2021-11-30
AU2020245203A1 (en) 2021-11-11
KR20210143254A (en) 2021-11-26
CN114072139A (en) 2022-02-18
EP3946311A4 (en) 2022-12-28
JP2022527621A (en) 2022-06-02
CA3134531A1 (en) 2020-10-01
EP3946311A1 (en) 2022-02-09
WO2020197816A1 (en) 2020-10-01
MX2021011589A (en) 2021-12-15
SG11202110423UA (en) 2021-10-28

Similar Documents

Publication Publication Date Title
IL283905A (en) Methods and compositions for delivery of carbon dioxide
IL283840A (en) Compositions for the delivery of therapeutic agents and methods of use and making thereof
IL282600A (en) Composition and method for treating the lungs
IL292810A (en) Therapeutic compounds and methods of use
IL276247A (en) Methods and compositions for treating sleep apnea
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3801552A4 (en) Composition and method for inhalation
IL276148A (en) Composition and method for reducing thrombocytopenia via the administration of plinabulin
IL287966A (en) Auto-injector and related methods of use
IL284082A (en) Silk-hyaluronic acid tissue fillers and methods of making and using the same
IL275767A (en) Compositions and methods for treating metabolic diseases
IL285197A (en) Methods and compositions for treating sleep apnea
SG11202100533VA (en) Hepato-biliary-pancreatic tissues and methods of making same
SG11202110484VA (en) Neuregulin-4 compounds and methods of use
HUE062202T2 (en) Sustained-release anesthetic compositions and methods of preparation thereof
IL276053A (en) Therapeutic-gard and method of use thereof
IL287829A (en) Progranulin modulators and methods of using the same
IL276792A (en) Inhaler and methods of use thereof
GB202009064D0 (en) Compounds and methods of use
IL286624A (en) Anesthetic composition and method of anesthetizing the eye
IL280868A (en) Compositions and methods for treatment of acute lung injury
GB2579687B (en) Composition and method
GB201914777D0 (en) Composition and method
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
IL282671A (en) Therapeutic methods and compositions